JAK2 and epilepsy: Angelica polysaccharide mitigated LPS-evoked inflammatory injury through repression of NF-κB and JAK2/STAT3 pathways by regulating miR-10a in HT22 cells. The discoveries offered a novel strategy for the clinical remedy of epilepsy.